BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 18, 2005
View Archived Issues
CYT006-AngQb: preclinical validation and further study in healthy volunteers
Read More
Novel lactam sodium channel blocker displays anticonvulsant activity
Read More
sanofi -aventis profiles pipeline development
Read More
Pfizer's new nNOS inhibitors demonstrate efficacy for pain and stroke
Read More
Antidepressant effects of two new triple reuptake inhibitors
Read More
Preclinical efficacy of FG-3019 against diabetes-associated metabolic/cardiovascular complications
Read More
Good safety and pharmacokinetic data reported for ANA-975 in monkeys and humans
Read More
Clinical evidence supports the use of CpG-10101 in hepatitis C
Read More
Gilead and Roche settle Tamiflu dispute
Read More
Johnson & Johnson and Guidant amend acquisition agreement
Read More
ev3 and Micro Therapeutics announce merger agreement
Read More
Medarex anticipates milestone payment from Bristol-Myers Squibb
Read More
Phase II study evaluates TroVax with IL-2 for metastatic renal cell carcinoma
Read More
Pivotal Veronate phase III study completes enrollment
Read More
Abraxane licensed to Taiho for Japan
Read More
Xenome begins phase I/II study for XEN-2174 for severe intractable pain
Read More
SNS-595 studied for refractory acute leukemia in phase I trial
Read More
Cardioprotective effects of a new plasminogen activator inhibitor
Read More
Reverse D-4F: potential in atherosclerosis
Read More
Anticancer potential of novel chalcones
Read More
AC-260584: an atypical M1 agonist with an ectopic binding site
Read More
ABT-127: Abbott's new D3 receptor antagonist targeted as an antipsychotic
Read More
Enhanced antitumor activity with IMC-3G3 plus doxorubicin in a leiomyosarcoma model
Read More
GNS-037: A novel HCV entry inhibitor
Read More
Novel HERG channel activator NS-1643 under investigation for treatment of arrhythmias
Read More
Shanghai Sunway Biotech's H101 approved for refractory nasopharyngeal cancer
Read More
Recent CNRS patent discloses novel MRI agents
Read More
Recent patents disclose novel agents for the treatment of endocrine-related disorders
Read More